Genome wide identification of recessive cancer genes by combinatorial mutation analysis

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Volinia, Stefano ^a,b   Mascellani, Nicoletta ^a   Marchesini, Jlenia ^a   Veronese, Angelo ^c   Ormondroyd, Elizabeth ^d   Alder, Hansjuerg ^b   Palatini, Jeff ^b   Negrini, Massimo ^c   Croce, Carlo M ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

^c Dipartimento di Medicina Sperimentale e Diagnostica   (Italy)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; PROTEIN TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE DELETION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOSS; GENE MUTATION; GENE SEQUENCE; GENETIC DATABASE; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; RECESSIVE GENE; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR GENE; EXPRESSED SEQUENCE TAG; GENETICS; GENOME; METHODOLOGY; MICROARRAY ANALYSIS; MOLECULAR GENETICS; MUTATION; NEOPLASM; NUCLEIC ACID DATABASE; NUCLEOTIDE SEQUENCE;

AMINO ACID SUBSTITUTION; DATABASES, NUCLEIC ACID; DNA MUTATIONAL ANALYSIS; EXPRESSED SEQUENCE TAGS; GENES, NEOPLASM; GENES, RECESSIVE; GENOME; HUMANS; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS;

EID: 54449096350     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003380     Document Type: Article

References (25)

1. Croce CM (2008) Oncogenes and cancer. N Engl J Med 358: 502-511.
2. Reddy EP, Reynolds RK, Santos E, Barbacid M (1982) A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300: 149-152.
3. Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, et al. (1982) Mechanism of activation of a human oncogene. Nature 300: 143-149.
4. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, et al. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430: 1034-1039.
5. Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, et al. (2008) Cancer proliferation gene discovery through functional genomics. Science 319: 620-624.
6. Murphy JA, Barrantes-Reynolds R, Kocherlakota R, Bond JP, Greenblatt MS (2004) The CDKN2A database: Integrating allelic variants with evolution, structure, function, and disease association. Hum Mutat 24: 296-304.
7. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, et al. (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19: 607-614.
8. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, et al. (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21: 577-581.
9. Garnett MJ, Marais R (2004) Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6: 313-319.
10. Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, et al. (2004) Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304: 1164-1166.
11. Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, et al. (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 349: 1505-1510.
12. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, et al. (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646.
13. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
14. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, et al. (2002) Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 346: 645-652.
15. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
16. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
17. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, et al. (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.
18. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
19. Irizarry K, Kustanovich V, Li C, Brown N, Nelson S, et al. (2000) Genome-wide analysis of single-nucleotide polymorphisms in human expressed sequences. Nat Genet 26: 233-236.
20. Qiu P, Wang L, Kostich M, Ding W, Simon JS, et al. (2004) Genome wide in silico SNP-tumor association analysis. BMC Cancer 4: 4.
21. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
22. Stratton M (2008) Genome resequencing and genetic variation. Nat Biotechnol 26: 65-66.
23. Davison AC, Hinkley DV (1997) Bootstrap Methods and Their Application. Press CU, editor. Cambridge.
24. Efron B, Tibshirani RJ (1993) An Introduction to the Bootstrap. Hall C, editor. London. 436 p.
25. Maere S, Heymans K, Kuiper M (2005) BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21: 3448-3449.